The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPEU.L Regulatory News (DPEU)

  • There is currently no data for DPEU

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on the Unsolicited Offer from Jubilant

5 Dec 2023 07:00

RNS Number : 6359V
DP Eurasia N.V
05 December 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

FOR IMMEDIATE RELEASE

 5 December 2023

DP Eurasia N.V.

("DP Eurasia" or the "Company")

Update on the Unsolicited Offer from Jubilant Foodworks

Further to its announcement of 1 December 2023, the board of DP Eurasia, excluding Directors conflicted by virtue of their being representatives of Jubilant Foodworks Netherlands B.V. ("Jubilant") (the "Board"), provides the following update in respect of Jubilant's announcement of 28 November 2023 that it intends to make an offer at an offer price of 85 pence per DP Eurasia ordinary share (the "Jubilant Proposal").

Having worked openly and constructively with Jubilant, the Board remains extremely disappointed that Jubilant decided to proceed in this unsolicited and opportunistic way and without first seeking to reach an agreement on terms which the Board would be able to endorse as being in the best interests of all stakeholders.

The Board has evaluated the Jubilant Proposal with its advisors and believes the financial terms fundamentally undervalue the Company and its prospects.

The Board has received feedback from a significant proportion of the Company's shareholders, indicating that they are also overwhelmingly of the opinion that the Jubilant Proposal fundamentally undervalues the Company.

The Board is determined to protect the interests of the Company's minority shareholders and other stakeholders.

The Board continues to advise shareholders to take no action.

Enquiries

DP Eurasia N.V.

 

?lknur Kocaer, CFA - Investor Relations Director

+90 212 280 9636

 

Buchanan (Financial Communications)

Richard Oldworth / Toto Berger / Verity Parker

+44 20 7466 5000

dp@buchanan.uk.com

Liberum (Financial Adviser & Corporate Broker)

Corporate Broking: Andrew Godber / Edward Thomas / Will King

M&A: Tim Medak / Mark Harrison / Matthew Hogg

 

+44 20 3100 2000

 

 

Important Notices

 

Liberum Capital Limited ("Liberum"), which is authorised and regulated in the United Kingdom by the FCA, is acting as financial adviser exclusively for the Company and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters set out in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Liberum, nor for providing advice in relation to the contents of this announcement or any other matter referred to herein. Neither Liberum nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Liberum in connection with this announcement, any statement contained herein or otherwise. Neither Liberum nor any of its affiliates nor any of their respective directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to, the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company.

 

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to this announcement or otherwise. The distribution of this announcement in jurisdictions other than the United Kingdom and the availability of any offer to shareholders of the Company who are not resident in the United Kingdom may be affected by the laws of relevant jurisdictions. Therefore, any persons who are subject to the laws of any jurisdiction other than the United Kingdom or shareholders of the Company who are not resident in the United Kingdom will need to inform themselves about, and observe any applicable requirements.

 

Forward-looking statements

 

This document, including information included or incorporated by reference in this document, may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "targets", "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts and involve predictions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect the Company's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Company's business, results of operations, financial position, liquidity, prospects, growth or strategies and the industry in which it operates. Forward-looking statements speak only as of the date they are made and cannot be relied upon as a guide to future performance. There are many factors that could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among such factors are changes in the global, political, social, economic, business, competitive, market and regulatory forces, future exchange and interest rates, changes in tax rates, future business combinations or disposals, and any epidemic, pandemic or disease outbreak.

 

These forward-looking statements are based on numerous assumptions regarding the present and future business strategies of such persons and the environment in which each will operate in the future. By their nature, these forward-looking statements involve known and unknown risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. The factors described in the context of such forward-looking statements in this document may cause the actual results, performance or achievements of any such person, or industry results and developments, to be materially different from any results, performance or achievements expressed or implied by such forward-looking statements. No assurance can be given that such expectations will prove to have been correct and persons reading this document are therefore cautioned not to place undue reliance on these forward-looking statements that speak only as at the date of this document. All subsequent oral or written forward-looking statements attributable to the Company or its affiliates or any persons acting on its behalf are expressly qualified in their entirety by the cautionary statement above. The Company does not intend, nor undertakes any obligation, to update publicly or revise forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

No profit forecasts or estimates

 

Nothing in this announcement is intended or shall be deemed to be a forecast, projection or estimate of the future financial performance of the Company and no statement in this announcement should be interpreted to mean that earnings or earnings per share of the Company for the current or future financial years would necessarily match or exceed the historical published earnings or earnings per share for the Company.

 

UK Market Abuse Regulation

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 of the European Parliament and the Council of 16 April 2014 as it forms part of domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAPALELNDFFA
Date   Source Headline
22nd Apr 20217:00 amRNSNotice of 2021 AGM
21st Apr 20211:24 pmRNSResults of 2021 Extraordinary General Meeting
8th Apr 20217:00 amRNS2020 Annual Report
23rd Mar 20217:00 amRNSPreliminary Results
10th Mar 20217:00 amRNSNotice of Extraordinary General Meeting
26th Feb 20211:12 pmRNSResults of 2021 EGM – Correction
24th Feb 20217:00 amRNSNotification of Preliminary Results
19th Feb 20215:23 pmRNSNotification of Major Holdings
19th Feb 20214:20 pmRNSNotification of Major Holdings
19th Feb 20214:20 pmRNSShareholder Update
19th Feb 202111:13 amRNSImportant Notice
3rd Feb 20212:49 pmRNSResults of 2021 Extraordinary General Meeting
1st Feb 20217:00 amRNSIntended NED Appointment
26th Jan 20217:00 amRNSFY20 Trading Update
7th Jan 20217:00 amRNSNotice of Trading Update
23rd Dec 20207:00 amRNSNotice of Extraordinary General Meeting
15th Dec 20207:00 amRNSConsideration of additional listing venue
18th Nov 20207:00 amRNSTrading Update
30th Oct 20207:00 amRNSNotice of Trading Update
15th Oct 20205:53 pmRNSDirectorate Update
8th Sep 20207:00 amRNSInterim Results
13th Aug 20207:00 amRNSNotification of Interim Results
21st Jul 20207:00 amRNSTrading Update
29th Jun 20207:00 amRNSNotice of Trading Update
3rd Jun 20202:32 pmRNSResults of 2020 Annual General Meeting
3rd Jun 20207:00 amRNSTrading Update
22nd Apr 20202:43 pmRNSCOVID-19 Update
22nd Apr 20207:00 amRNSNotice of 2020 AGM
27th Mar 20207:00 amRNS2019 Results
27th Mar 20207:00 amRNS2019 Annual Report
24th Mar 20205:18 pmRNSUpdate on publication of results
12th Mar 20207:00 amRNSNotification of Preliminary Results – Update
25th Feb 20207:00 amRNSNotification of Preliminary Results
28th Jan 20207:00 amRNSTrading Update for the Year Ended 31 December 2019
6th Jan 20207:00 amRNSNotice of Trading Update
11th Sep 20197:00 amRNSInterim Results
9th Aug 20197:00 amRNSNotification of Interim Results
15th Jul 20197:00 amRNSTrading Update
28th Jun 20197:00 amRNSNotice of Trading Update
26th Jun 20197:00 amRNSVALUE REALISATION FOR STAKE IN DP EURASIA N.V.
31st May 20193:45 pmRNSSenior Management Change
29th May 20192:59 pmRNSResults of 2019 Annual General Meeting
11th Apr 20197:00 amRNS2018 Annual Report and Notice of 2019 AGM
2nd Apr 20197:00 amRNSPreliminary Results
19th Feb 20197:00 amRNSNotification of Preliminary Results
17th Jan 20197:00 amRNSTrading Update - Strong top line growth
24th Dec 20187:00 amRNSNotice of Trading Update
11th Sep 20187:00 amRNSInterim Results for the Period Ended 30 June 2018
9th Aug 20187:00 amRNSNotification of Interim Results
13th Jul 20187:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.